Medications

Tirzepatide improves kidney outcomes in T2DM with increased CV risk

An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new onset of macroalbuminuria; ...

Cardiology

Gender gap in some heart risk factors widens among young adults

Gender gaps in blood pressure, physical activity and smoking have widened among young adults in the United States, new research finds, suggesting that prevention approaches should be carefully tailored to help people achieve ...

page 1 from 40